Azacitidine/Cedazuridine
- Generic Name
- Azacitidine/Cedazuridine
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04608110
- Locations
- 🇯🇵
Yamagata University Hospital, Yamagata, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath